Last Updated: 12 Jun 2025
Source: Statifacts
The global clinical trial biorepository and archiving solutions market size surpassed USD 4.66 billion in 2024 and is predicted to reach around USD 12.06 billion by 2034, registering a CAGR of 9.97% from 2025 to 2034.
| Industry Worth | Details |
| Market Size in 2025 | USD 5.07 Billion |
| Market Size by 2034 | USD 12.06 Billion |
| Market Growth Rate from 2025 to 2034 | CAGR of 9.97% |
The clinical trial biorepository and archiving solutions in which biorepository is a facility that collects, catalogs, and stores samples of biological materials like protein, DNA, RNA, cells, tissue, blood, and urine from plants, humans, or animals for laboratory research and clinical trial archiving includes planning, implementing, and maintaining a repository of documents and electronic records containing clinical information, supporting documentation, and any interpretations from a clinical trial. Increasing investment in biobanking infrastructure, rising demand for long-term data storage and preservation, and growing demand for adhering to stringent regulations are driving the growth of the clinical trial biorepository and archiving solutions market.
Number of Clinical Trials By Country or Area
| By Country | Number of clinical trials |
| United States of America | 186497 |
| China | 135747 |
| India | 74031 |
| Japan | 65167 |
| Germany | 54902 |
AI streamlines clinical trials by improving protocol design, predicting outcomes, and analyzing big datasets. AI can aid participant recruitment by matching eligible patients to trials. AI can improve safety monitoring with real-time alerts for adverse events. AI can be used to stimulate data to detect more effective statistical outcome measures. AI helps clinical data managers by automating time-consuming, complex data management processes in medical coding, data reconciliation, and ATRs. Healthcare AI systems can analyze patterns in a patient’s medical history and current health data to predict potential health risks.
Dan Shine, senior vice president and president of analytical instruments, Thermo Fischer, said, “At Thermo Fischer Scientific, we are revolutionizing the scientific landscape and delivering unprecedented insights that drive progress where our customers need it most.” “By combining higher performing instruments with technology that supports innovative, end-to-end workflows, we are helping researchers expedite discoveries that will impact human health, drug development, and environmental sustainability.”
Alex Esmon, Vice President and General Manager of Global Products at Azenta Life Sciences, said, “We are excited to support UK Biocentre with the advanced automation sample storage capabilities of the BioArc Ultra.” “The addition of the BioArc Ultra delivers on the promise of enabling breakthroughs faster through substantial improvements in proven automation and refrigeration that ensure critical sample integrity while streamlining workflows and ensuring sustainability.”
North America held a significant share of the clinical trial biorepository and archiving solutions market in 2024. Rising investment in biobanking infrastructure, increasing demand for long-term data storage and preservation, rising demand for adhering to stringent regulations, and an increase in clinical trials are driving the growth of the market in the North American region.
Asia Pacific is projected to host the fastest-growing market in the coming years. Increasing adoption of advanced technologies, advancements in automation, supporting global research, and innovative healthcare solutions are driving the clinical trial biorepository and archiving solutions market in the Asia Pacific.
Over 50 countries where it operates. It operates in the clinical research and life science sectors around the world.
It operates in several countries. It operates in the life science sectors around the world.
Published by Ajit Bansod
